You finish a hard training block, get your blood checked and find several results marked high or low. The obvious question is whether something is wrong. The less obvious question is what the laboratory's comparison actually tells you. A flag means that your result sits outside a particular reference interval. It is a reason to interpret the result, not a diagnosis by itself.
For strength athletes, this distinction is useful. Muscle mass and recent exercise can affect certain tests. But the opposite claim, that standard laboratory ranges do not apply to athletes, goes too far. Many results remain clinically meaningful, including changes caused by anabolic steroids. A drug effect can explain an abnormality and still be a reason to investigate or change treatment.
Learning how ranges work helps you avoid two expensive mistakes: treating a benign variation as an illness and dismissing a significant problem because it is common in your sport. This article focuses on the meaning of the numbers beside your results, rather than giving you a substitute table of supposedly safe bodybuilding values.
What a reference interval describes
A laboratory reference interval usually describes the central 95% of results in a selected reference population. In that statistical model, some healthy people fall outside the interval. The interval may differ by age, sex, pregnancy status or laboratory method, depending on the test. The people used to establish it are selected according to defined criteria; it is inaccurate to assume every range comes from sedentary or unhealthy adults.
Laboratories do not necessarily recruit a completely new population for every test. They may establish their own interval or verify one developed elsewhere for the method they use. The Clinical and Laboratory Standards Institute sets out procedures for establishing and verifying these comparisons. That process includes the reference population and the conditions under which samples were obtained.
The practical implication is straightforward: use the interval printed by the laboratory that performed the test. An online chart may use a different method, different units or a different population. If you change laboratories and notice a small shift, check those details before assuming your physiology changed. A result can be analytically correct and still be difficult to compare with an older result.
Why a flag does not equal disease
Reference intervals describe a distribution. They do not tell you the probability of a particular disease from a single number. A mild abnormality can reflect ordinary variation, collection conditions, medication, illness or a clinically important problem. Which explanation is most plausible depends on the marker and the rest of the assessment.
Ordering many tests also increases the chance of seeing something outside an interval. As a simple mathematical illustration, if twenty tests were independent and each placed 5% of healthy people outside its interval, the chance of at least one flag would be about 64%. Real blood markers are often related, so that calculation is not a prediction for your panel. It shows why counting flags is a poor health assessment.
The reverse also matters. A person can have disease or elevated long-term risk with results inside a reference interval. Early kidney disease can include urine albumin despite preserved filtration. Cardiovascular risk depends on more than one cholesterol value. A report with no red rows means the measured results met those comparisons on that day; it does not mean every possible health problem was excluded.
Decision thresholds answer another question
A clinical decision threshold is chosen to guide an investigation or treatment decision. It may be based on research connecting a measurement with outcomes, or on a professional guideline balancing benefits and harms. It is not simply the top or bottom of a healthy population's distribution.
Hematocrit during testosterone treatment provides a clear example. The Endocrine Society testosterone guideline advises withholding therapy when hematocrit exceeds 54%, investigating hypoxia and sleep apnea, and resuming at a reduced dose once appropriate. That recommendation cannot be replaced with “54% is normal for steroid users.” The fact that testosterone increases red-cell production is the reason monitoring is needed.
Similarly, a cholesterol treatment decision depends on overall cardiovascular risk, not just whether LDL sits inside a broad laboratory range. Previous cardiovascular disease, diabetes, smoking, blood pressure and family history can change the discussion. A result described as average for a group is not automatically a desirable treatment target for each individual in that group.
Where muscle mass really changes interpretation
Creatinine is produced from creatine metabolism, largely associated with skeletal muscle. Someone carrying more muscle may produce more creatinine than another person with the same kidney filtration. Recent strenuous training, meat intake and creatine use may add further context. A creatinine-based estimate of filtration can therefore be misleading in some muscular people.
That does not establish a universal creatinine allowance for bodybuilders. A new increase still needs explanation, and muscle mass does not protect against kidney disease. The KDIGO guideline supports using additional filtration assessment when creatinine is less reliable and checking urine albumin in people at risk. Cystatin C can help, often through a combined creatinine-cystatin C estimate, but it also has influences unrelated to filtration.
The useful question is whether the available tests agree and whether the pattern persists. A stable creatinine result, a reassuring combined estimate, normal urine findings and an appropriate clinical assessment provide more information than accepting an isolated eGFR as either certain disease or certain muscle artifact. See creatinine and eGFR in muscular adults for the full interpretation.
Where recent training changes interpretation
Hard exercise can raise CK, AST and ALT because those enzymes are present in muscle. The response depends on the workload, how accustomed you are to it and the time since the session. An unfamiliar workout that leaves you unusually sore can have a different laboratory effect from a familiar session at the same perceived effort.
In a small weightlifting experiment in healthy men, AST and ALT remained elevated for at least seven days after an intensive session. This is useful evidence that exercise can interfere with interpretation. It does not define a safe upper enzyme level or prove that every trained person's elevation comes from muscle.
A clinician may consider CK, bilirubin, alkaline phosphatase, GGT, symptoms and exposure history, then repeat testing after adequate recovery when appropriate. Normal GGT does not exclude liver injury. Severe muscle pain, weakness, dark urine or reduced urine output also change the assessment; they should not be dismissed as an impressive training response. The muscle-versus-liver guide explains why the whole pattern matters.
Why drug exposure is different from athletic adaptation
Anabolic steroids can lower HDL, suppress LH and FSH, alter SHBG and raise hematocrit. These are recognizable pharmacological effects. Recognizable does not mean harmless, and grouping them with training-related CK changes conceals important differences. Some are consequences of the drug exposure that warrant monitoring or a discussion about stopping it.
The prospective HAARLEM study of androgen use found changes in blood pressure, lipids and hematocrit during exposure. The study followed users rather than assigning a standardized bodybuilding regimen, so it cannot rank every individual combination or establish a safe dose. It supports taking predictable changes seriously rather than redefining them as normal.
Prescribed TRT also needs its own context. It aims to treat a diagnosed deficiency, with treatment and follow-up tailored by a clinician. Supraphysiological testosterone during bodybuilding use is not made equivalent to replacement therapy because the same molecule is involved. A laboratory classification can describe the exposure; it cannot decide whether the benefits outweigh the risks for you.
Use your baseline without turning it into a target
Your previous results help identify change. If creatinine has been stable for years, that is relevant to interpreting a new measurement. If hematocrit rises across several draws, the direction matters even before it crosses a treatment threshold. Keep the original reports and collection conditions so that a clinician can judge whether the comparison is fair.
Your baseline may itself include a problem. A consistently high blood pressure or persistently elevated ApoB does not become desirable because it predates a cycle. “Normal for me” should mean a documented pattern that has been assessed, not a personal exemption from prevention. Absolute values and trends answer complementary questions, and both belong in the conversation.
When a repeat is planned, ask what it will clarify. Are you checking whether the exercise effect has settled, confirming an unexpected result or following the response to a prescribed treatment change? That question determines useful timing. Repeating the same panel under poorly documented conditions can reproduce the uncertainty without resolving it.
Bring a better question to the appointment
Instead of arguing that the laboratory range is wrong, explain why a particular influence might matter. “I did unfamiliar eccentric leg training two days before the draw, and my CK is also raised” is useful information. So is an honest list of testosterone, other drugs and supplements. It helps your clinician test an explanation rather than guess at one.
Ask whether the result represents a statistical flag, a treatment threshold, a change from baseline or some combination of the three. Ask which additional information would change the interpretation and who will review it. You should leave with a plan that relates to the actual concern, not a blanket instruction to ignore athlete flags or chase every result into the middle of its range.